Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 249

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Elevated micro RNA‐34a in obesity reduces NAD+ levels and SIRT 1 activity by directly targeting NAMPT

Open access
Choi, Sung‐E, Fu, Ting, Seok, Sunmi, Kim, Dong‐Hyun, Yu, Eunkyung, Lee, Kwan‐Woo, Kang, Yup, Li, Xiaoling, Kemper, Byron, Kemper, Jongsook K.·2013·Aging Cell

Abstract

Summary: SIRT1 is an NAD+‐dependent deacetylase that is implicated in prevention of many age‐related diseases including metabolic disorders. As SIRT1 deacetylase activity is dependent on NAD+ levels and the development of compounds that directly activate SIRT1 has been controversial, indirectly activating SIRT1 through enhancing NAD+ bioavailability has received increasing attention. NAD+ levels are reduced in obesity and the aged, but the underlying mechanisms remain unclear. We recently showed that hepatic microRNA‐34a (miR‐34a), which is elevated in obesity, directly targets and decreases SIRT1 expression. Here, we further show that miR‐34a reduces NAD+ levels and SIRT1 activity by targeting NAMPT, the rate‐limiting enzyme for NAD+ biosynthesis. A functional binding site for miR‐34a is present in the 3′ UTR of NAMPT mRNA. Hepatic overexpression of miR‐34a reduced NAMPT/NAD+ levels, increased acetylation of the SIRT1 target transcriptional regulators, PGC‐1α, SREBP‐1c, FXR, and NF‐κB, and resulted in obesity‐mimetic outcomes. The decreased NAMPT/NAD+ levels were independent of miR‐34a effects on SIRT1 levels as they were also observed in SIRT1 liver‐specific knockout mice. Further, the miR‐34a‐mediated decreases were reversed by treatment with the NAD+ intermediate, nicotinamide mononucleotide. Conversely, antagonism of miR‐34a in diet‐induced obese mice restored NAMPT/NAD+ levels and alleviated steatosis, inflammation, and glucose intolerance. Anti‐miR‐34a‐mediated increases in NAD+ levels were attenuated when NAMPT was downregulated. Our findings reveal a novel function of miR‐34a in reducing both SIRT1 expression and activity in obesity. The miR‐34a/NAMPT axis presents a potential target for treating obesity‐ and aging‐related diseases involving SIRT1 dysfunction like steatosis and type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.12135

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 249

Metadata

Authors
Choi, S., Fu, T., Seok, S., Kim, D., Yu, E., Lee, K., Kang, Y., Li, X., Kemper, B., & Kemper, J. K.
Venue
Aging Cell
Publisher
Wiley
Published
2013-08-11
Volume
12
Issue
6
Pages
1062-1072
ISSN
  • 1474-9718 (ISSN-L)
  • 1474-9726
OpenAlex
W1975400918
Cited by
249
References
17
FWCI
8.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated micro RNA‐34a in obesity reduces NAD+ levels and SIRT 1 activity by directly targeting NAMPT. https://app.cochat.ai/papers/10.1111/acel.12135
The paper
Choi, S., Fu, T., Seok, S., Kim, D., Yu, E., Lee, K., Kang, Y., Li, X., Kemper, B., & Kemper, J. K. (2013). Elevated micro RNA‐34a in obesity reduces NAD+ levels and SIRT 1 activity by directly targeting NAMPT. Aging Cell. https://doi.org/10.1111/acel.12135

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.